Mazdutide
GLP-1/glucagon dual receptor agonist. Weight and metabolic research.
For research use only · Not for human consumption
Every source for Mazdutide
Affiliate disclosure: purchases through links below may earn us a commission. Rankings are never sold — methodology · full disclosure
- ✓Third-party tested (Verified)
- ✓COAs provided — Per-batch
- ✓Best $/mg in stock right now
- ✓4.6★ community rating
The research base
Phase 3 dual GLP-1/glucagon agonist showing strong weight reduction and metabolic improvements in trials.
How it works
Dual agonist at GLP-1 and glucagon receptors. Combines appetite suppression with increased energy expenditure via glucagon signaling.
Common research protocols
Phase 2/3 trials used escalating doses to 9mg. Start low and titrate to minimize GI effects. Dual glucagon action increases energy expenditure relative to pure GLP-1 agonists.
As a solo compound
Standalone use is standard for metabolic research. Requires careful titration.
What to know
GI effects (nausea, reduced appetite) most common, dose-dependent. Titration reduces severity.
Realistic expectations
Titrate over weeks; effects build over months
